Tenax Therapeutics (TENX) S-3Shelf registration

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 of our report dated March 30, 2020, relating to the consolidated financial statements of Tenax Therapeutics, Inc. (the “Company”), appearing in the Annual Report on Form 10-K of the Company as of and for the years ended December 31, 2019 and 2018. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern. We also consent to the reference of our firm under the heading “Experts” in the prospectus.

 

 

/s/ CHERRY BEKAERT LLP

 

Raleigh, North Carolina

August 20, 2020